1210004-12-8,MFCD18382122
Catalog No.:AA008SP9

1210004-12-8 | JZL 195

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
≥98%
in stock  
$88.00   $61.00
- +
10mg
≥98%
in stock  
$160.00   $112.00
- +
50mg
≥98%
in stock  
$669.00   $468.00
- +
100mg
≥98%
in stock  
$1,166.00   $816.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA008SP9
Chemical Name:
JZL 195
CAS Number:
1210004-12-8
Molecular Formula:
C24H24ClN3O5
Molecular Weight:
469.9175
MDL Number:
MFCD18382122
SMILES:
O=C(N1CCN(CC1)Cc1cccc(c1)Oc1ccccc1)Oc1ccc(cc1)[N+](=O)[O-].Cl
Properties
Computed Properties
 
Complexity:
605  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
32  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
6  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
4.3  

Literature

Title: Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model.

Journal: British journal of pharmacology 20160101

Title: Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice.

Journal: The Journal of pharmacology and experimental therapeutics 20150801

Title: The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents.

Journal: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20150701

Title: A high-throughput, multiplexed assay for superfamily-wide profiling of enzyme activity.

Journal: Nature chemical biology 20140801

Title: Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model.

Journal: Neuropharmacology 20140601

Title: Assay and inhibition of diacylglycerol lipase activity.

Journal: Bioorganic & medicinal chemistry letters 20120715

Title: Characterization of tunable piperidine and piperazine carbamates as inhibitors of endocannabinoid hydrolases.

Journal: Journal of medicinal chemistry 20100225

Title: Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.

Journal: Proceedings of the National Academy of Sciences of the United States of America 20091201

Title: Long JZ, et al. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20270-5.

Title: Anderson WB, et al. Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model. Neuropharmacology. 2014 Jun;81:224-30.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1210004-12-8
Tags:1210004-12-8 Molecular Formula|1210004-12-8 MDL|1210004-12-8 SMILES|1210004-12-8 JZL 195
Catalog No.: AA008SP9
1210004-12-8,MFCD18382122
1210004-12-8 | JZL 195
Pack Size: 5mg
Purity: ≥98%
in stock
$88.00 $61.00
Pack Size: 10mg
Purity: ≥98%
in stock
$160.00 $112.00
Pack Size: 50mg
Purity: ≥98%
in stock
$669.00 $468.00
Pack Size: 100mg
Purity: ≥98%
in stock
$1,166.00 $816.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA008SP9
Chemical Name: JZL 195
CAS Number: 1210004-12-8
Molecular Formula: C24H24ClN3O5
Molecular Weight: 469.9175
MDL Number: MFCD18382122
SMILES: O=C(N1CCN(CC1)Cc1cccc(c1)Oc1ccccc1)Oc1ccc(cc1)[N+](=O)[O-].Cl
Properties
Complexity: 605  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 32  
Hydrogen Bond Acceptor Count: 6  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 6  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 4.3  
Literature fold

Title: Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model.

Journal: British journal of pharmacology20160101

Title: Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice.

Journal: The Journal of pharmacology and experimental therapeutics20150801

Title: The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents.

Journal: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society20150701

Title: A high-throughput, multiplexed assay for superfamily-wide profiling of enzyme activity.

Journal: Nature chemical biology20140801

Title: Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model.

Journal: Neuropharmacology20140601

Title: Assay and inhibition of diacylglycerol lipase activity.

Journal: Bioorganic & medicinal chemistry letters20120715

Title: Characterization of tunable piperidine and piperazine carbamates as inhibitors of endocannabinoid hydrolases.

Journal: Journal of medicinal chemistry20100225

Title: Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.

Journal: Proceedings of the National Academy of Sciences of the United States of America20091201

Title: Long JZ, et al. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20270-5.

Title: Anderson WB, et al. Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model. Neuropharmacology. 2014 Jun;81:224-30.

Building Blocks More >
1028205-76-6
1028205-76-6
2,3,4,5,6-Pentamethylphenylboronic acid
AA008SSP | MFCD06801718
112362-50-2
112362-50-2
Dalfopristin
AA008T0Y | MFCD00895414
1092536-54-3
1092536-54-3
4-Benzyloxy-3,3-dimethylbut-1-yne
AA008TB8 | MFCD23106327
1208319-26-9
1208319-26-9
Oclacitinib
AA008TFW | MFCD25976611
1089736-73-1
1089736-73-1
L-Valine, N-(1-oxopentyl-d9)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]Methyl]-
AA008TKL | MFCD08063540
107485-63-2
107485-63-2
2-Bromo-6-fluorobenzamide
AA008TQO | MFCD07368694
1006463-47-3
1006463-47-3
N'-(1-Isopropyl-1H-pyrazol-5-yl)-N-methylfuran-2-carboximidamide
AA008TZ9 | MFCD07366386
112372-15-3
112372-15-3
Furo[2,3-c]pyridine-2-carboxylic acid
AA008U7F | MFCD11869932
10417-63-7
10417-63-7
11beta,17alpha,21-Trihydroxy-16alpha-Methyl-1,4-pregnadiene-3,20-dione
AA008UHF | MFCD28358923
106726-11-8
106726-11-8
NEODYMIUM NEODECANOATE
AA008URC
Submit
© 2017 AA BLOCKS, INC. All rights reserved.